AzTrials
AzTrials

Penetrating Injury in Upper LimbPhase 2NCT01253863

Diagnostic Accuracy of the Preoperative Clinical Examination in Upper Limb Injuries

A Phase 2 study testing exploration in people with Penetrating Injury in Upper Limb, run by Isfahan University of Medical Sciences at 1 site in Iran.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the accuracy of preoperative clinical examination in penetrating injuries Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Penetrating Injury in Upper Limb
What is being tested?
exploration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
1 siteIran
Study dates
Aug 2006to Sep 2009
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Deep penetrating injury to upper limb

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Iran1 site
  • Al-zahra university hospital

    Isfahan, Isfahan

Other trials in Iran

About this study

Official title: Study of Accuracy of Preoperative Examination in Penetrating Wound

The purpose of this study is to determine the accuracy of preoperative clinical examination in penetrating injuries

Read the detailed description

Penetrating injuries is a common cause of severe neurovascular damage, both in adults and children.we evaluated the accuracy of the preoperative clinical examination in depicting lesions caused by penetrating wounds of hands or forearms.

Being tested
exploration
Keywords
Clinical Examination, Accuracy, Hand, Tendon, Injury.
Medical subject headings
Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • explorationOther

    exploration of wound for determining damaged tissue

Study groups in NCT01253863
Study groupRoleWhat they receive
determining damaged tissueOtherNot described
Receives: Other: exploration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. number of determined tendon

    we evalauted tendon injuries without exploration of wound

    Measured: 5 min after admission

Secondary outcomes (2)
  1. number of determined injured nerves

    we evaluated the number of detemined injured nerves without exploration of wound

    Measured: 5 min after admision

  2. number of damaged arteries

    we evaluated the number of detemined injured arteries without exploration of wound

    Measured: 5 min after admission

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2010 (estimated)
  2. Study startAug 2006
  3. Primary completionMay 2008
  4. Study completionSep 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01253863
Sponsor's protocol ID
ASD-1213-7
Status last verified
Aug 2006
First submitted
2 Dec 2010
Last updated
3 Dec 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing exploration in people with Penetrating Injury in Upper Limb, run by Isfahan University of Medical Sciences at 1 site in Iran.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Dec 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

number of determined tendon (time frame: 5 min after admission). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in